Article
Rovamycine as add-on treatment in unstable angina and 4 year evolution with major cardiovascular events.
3
TL;DRAbstract
In patients with unstable angina Rovamycine as add-on treatment to the conventional treatment lead to a significant decrease of MACE incidence at 6 months and to a significant decrease in the 4 years incidence of unstable angina with readmission. The beneficial effect of Rovamycine was parallel to the decrease in serum inflammations markers concentration.
Chat with Paper
AI Agents for this Paper
In patients with unstable angina Rovamycine as add-on treatment to the conventional treatment lead to a significant decrease of MACE incidence at 6 months and to a significant decrease in the 4 years incidence of unstable angina with readmission. The beneficial effect of Rovamycine was parallel to the decrease in serum inflammations markers concentration.
Keywords
Unstable anginaMedicineIncidence (geometry)MaceMyocardial infarctionInternal medicineChlamydiaAcute coronary syndrome
Chat
Click to start Chat